Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] NLMUID: 8707234"" wg kryterium: JN


Tytuł :
Letter: budesonide for functional dyspepsia with duodenal eosinophilia-randomised, double-blind, placebo-controlled parallel-group trial.
Autorzy :
Talley NJ; University of Newcastle, Newcastle, NSW, Australia.; NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, NSW, Australia.
Walker MM; University of Newcastle, Newcastle, NSW, Australia.; NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, NSW, Australia.
Jones M; NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, NSW, Australia.; Department of Psychology, Macquarie University, Ryde, NSW, Australia.
Keely S; University of Newcastle, Newcastle, NSW, Australia.; NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, NSW, Australia.
Koloski N; University of Newcastle, Newcastle, NSW, Australia.; NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, NSW, Australia.; Department of Psychology, Macquarie University, Ryde, NSW, Australia.; Department of Gastroenterology, Princess Alexander Hospital, Woolloongabba, Qld, Australia.
Cameron R; University of Newcastle, Newcastle, NSW, Australia.; NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, NSW, Australia.
Fairlie T; Department of Gastroenterology, Princess Alexander Hospital, Woolloongabba, Qld, Australia.
Burns G; University of Newcastle, Newcastle, NSW, Australia.; NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, NSW, Australia.
Shah A; NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, NSW, Australia.; Department of Gastroenterology, Princess Alexander Hospital, Woolloongabba, Qld, Australia.; School of Medicine, University of Queensland, St Lucia, Qld, Australia.
Hansen T; Department of Psychology, Macquarie University, Ryde, NSW, Australia.
Harris G; University of Newcastle, Newcastle, NSW, Australia.; NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, NSW, Australia.
Holtmann G; NHMRC Centre of Research Excellence in Digestive Health, New Lambton Heights, NSW, Australia.; Department of Gastroenterology, Princess Alexander Hospital, Woolloongabba, Qld, Australia.; School of Medicine, University of Queensland, St Lucia, Qld, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (12), pp. 1332-1333.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Dyspepsia*/drug therapy
Eosinophilia*/drug therapy
Gastroesophageal Reflux*
Budesonide/therapeutic use ; Double-Blind Method ; Humans
Raport
Tytuł :
Systematic review with meta-analysis: risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms.
Autorzy :
Eusebi LH; Gastroenterology and Endoscopy Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Telese A; Department of Gastroenterology, University College London Hospital (UCLH), London, UK.
Cirota GG; Gastroenterology and Endoscopy Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Haidry R; Department of Gastroenterology, University College London Hospital (UCLH), London, UK.
Zagari RM; Gastroenterology and Endoscopy Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Bazzoli F; Gastroenterology and Endoscopy Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Ford AC; Leeds Institute of Medical Research, St. James's University of Leeds, Leeds, UK.; Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 May; Vol. 53 (9), pp. 968-976. Date of Electronic Publication: 2021 Mar 11.
Typ publikacji :
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms :
Barrett Esophagus*/epidemiology
Barrett Esophagus*/etiology
Esophagitis, Peptic*
Gastroesophageal Reflux*/complications
Gastroesophageal Reflux*/epidemiology
Cross-Sectional Studies ; Humans ; Risk Factors
Czasopismo naukowe
Tytuł :
Letter: PPIs in EoE-More questions than answers.
Autorzy :
Miehlke S; Center for Digestive Diseases, Internal Medicine Center Eppendorf, Hamburg, Germany.; Center for Esophageal Diseases, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
von Arnim U; Department of Gastroenterology, Hepatology and Infectious Diseases, Otto von Guericke University, Magdeburg, Germany.
Attwood S; Department of Health Services Research, Durham University, Durham, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jan; Vol. 53 (2), pp. 364-365.
Typ publikacji :
Letter; Comment
MeSH Terms :
Eosinophilic Esophagitis*
Gastroesophageal Reflux*/drug therapy
Diagnostic Tests, Routine ; Humans ; Proton Pump Inhibitors/adverse effects ; Registries
Opinia redakcyjna
Tytuł :
Editorial: refractory GERD-does radiofrequency energy prevent the burn?
Autorzy :
Naik RD; Division of Gastroenterology, Hepatology, and Nutrition, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, TN, USA.
Vaezi MF; Division of Gastroenterology, Hepatology, and Nutrition, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, TN, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Sep; Vol. 52 (6), pp. 1069-1070.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Burns*
Gastroesophageal Reflux*/prevention & control
Heartburn ; Humans ; Proton Pump Inhibitors
Opinia redakcyjna
Tytuł :
Randomised clinical trial: oesophageal radiofrequency energy delivery versus sham for PPI-refractory heartburn.
Autorzy :
Zerbib F; Gastroenterology Department, CHU de Bordeaux, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Université de Bordeaux, INSERM CIC 1401, Bordeaux, France.
Sacher-Huvelin S; Gastroenterology Department, CHU de Nantes, Institut des Maladies de l'Appareil Digestif (IMAD), CIC1413, Université de Nantes, Nantes, France.
Coron E; Gastroenterology Department, CHU de Nantes, Institut des Maladies de l'Appareil Digestif (IMAD), CIC1413, Université de Nantes, Nantes, France.
Coffin B; Gastroenterology Department, AP-HP, Hôpital Louis Mourier, Colombes, Université de Paris, Paris, France.
Melchior C; Gastroenterology Department, Rouen University Hospital and INSERM CIC-CRB 1404 and INSERM U1073, Institute for Research and Innovation in Biomedicine, Normandy University, Rouen, France.
Ponchon T; Gastroenterology Department, CHU de Lyon, Hôpital Edouard Herriot, Université de Lyon, Lyon, France.
Cholet F; Gastroenterology Department, CHRU de Brest, Hôpital de la Cavale Blanche, Université de Brest, Brest, France.
Chabrun E; Gastroenterology Department, CHU de Bordeaux, Centre Medico-chirurgical Magellan, Hôpital Haut-Lévêque, Université de Bordeaux, INSERM CIC 1401, Bordeaux, France.
Vavasseur F; Gastroenterology Department, CHU de Nantes, Institut des Maladies de l'Appareil Digestif (IMAD), CIC1413, Université de Nantes, Nantes, France.
Gorbatchef C; Gastroenterology Department, AP-HP, Hôpital Louis Mourier, Colombes, Université de Paris, Paris, France.
Zalar A; Gastroenterology Department, Rouen University Hospital and INSERM CIC-CRB 1404 and INSERM U1073, Institute for Research and Innovation in Biomedicine, Normandy University, Rouen, France.
Mion F; Digestive Physiology Department, Hospices Civils de Lyon, Université de Lyon, Inserm U1082 LabTau, Lyon, France.
Robaszkiewicz M; Gastroenterology Department, CHRU de Brest, Hôpital de la Cavale Blanche, Université de Brest, Brest, France.
Le Rhun M; Gastroenterology Department, CHU de Nantes, Institut des Maladies de l'Appareil Digestif (IMAD), CIC1413, Université de Nantes, Nantes, France.
Leroy M; Methodology and Biostatistics Department, CHU de Nantes, Université de Nantes, Nantes, France.
Paul Galmiche J; Gastroenterology Department, CHU de Nantes, Institut des Maladies de l'Appareil Digestif (IMAD), CIC1413, Université de Nantes, Nantes, France.
Bruley des Varannes S; Gastroenterology Department, CHU de Nantes, Institut des Maladies de l'Appareil Digestif (IMAD), CIC1413, Université de Nantes, Nantes, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Aug; Vol. 52 (4), pp. 637-645. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Gastroesophageal Reflux/*therapy
Heartburn/*therapy
Proton Pump Inhibitors/*therapeutic use
Radiofrequency Therapy/*methods
Adolescent ; Adult ; Aged ; Combined Modality Therapy ; Double-Blind Method ; Drug Resistance/radiation effects ; Female ; France ; Gastroesophageal Reflux/complications ; Gastroesophageal Reflux/drug therapy ; Gastroesophageal Reflux/pathology ; Heartburn/drug therapy ; Heartburn/etiology ; Heartburn/pathology ; Humans ; Male ; Middle Aged ; Placebos ; Severity of Illness Index ; Treatment Failure ; Young Adult
Czasopismo naukowe
Tytuł :
Editorial: simultaneous prolonged monitoring of the acid pocket and oesophageal reflux.
Autorzy :
Katz PO; Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York, NY, USA.
Castell DO; Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, SC, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Jul; Vol. 52 (2), pp. 397-398.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Esophagitis, Peptic*
Gastroesophageal Reflux*
Alginates ; Aluminum Hydroxide ; Antacids ; Drug Combinations ; Humans ; Obesity ; Silicic Acid ; Sodium Bicarbonate
Opinia redakcyjna
Tytuł :
Editorial: simultaneous, prolonged monitoring of the acid pocket and oesophageal reflux. Authors' reply.
Autorzy :
Ma ZF; School of Medical Sciences, Universiti Sains Malaysia, Kota Bahru, Malaysia.; Department of Health and Environmental Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, China.
Deraman MA; School of Medical Sciences, Universiti Sains Malaysia, Kota Bahru, Malaysia.
Coyle C; Reckitt Benckiser, Slough, UK.
Lee YY; School of Medical Sciences, Universiti Sains Malaysia, Kota Bahru, Malaysia.; Gut Research Group, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.; St George and Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Jul; Vol. 52 (2), pp. 398-399.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Esophagitis, Peptic*
Gastroesophageal Reflux*
Alginates ; Aluminum Hydroxide ; Antacids ; Drug Combinations ; Humans ; Obesity ; Silicic Acid ; Sodium Bicarbonate
Opinia redakcyjna
Tytuł :
Randomised clinical trial: the effectiveness of Gaviscon Advance vs non-alginate antacid in suppression of acid pocket and post-prandial reflux in obese individuals after late-night supper.
Autorzy :
Deraman MA; School of Medical Sciences, Universiti Sains Malaysia, Kota Bahru, Malaysia.
Abdul Hafidz MI; Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Malaysia.
Lawenko RM; De La Salle Health Sciences Institute, Dasmarinas, Philippines.
Ma ZF; School of Medical Sciences, Universiti Sains Malaysia, Kota Bahru, Malaysia.; Department of Health and Environmental Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, China.
Wong MS; School of Medical Sciences, Universiti Sains Malaysia, Kota Bahru, Malaysia.
Coyle C; Reckitt Benckiser, Slough, UK.
Lee YY; School of Medical Sciences, Universiti Sains Malaysia, Kota Bahru, Malaysia.; Gut Research Group, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.; St George and Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Jun; Vol. 51 (11), pp. 1014-1021. Date of Electronic Publication: 2020 Apr 28.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Meals*/drug effects
Alginates/*therapeutic use
Aluminum Hydroxide/*therapeutic use
Antacids/*therapeutic use
Gastroesophageal Reflux/*drug therapy
Silicic Acid/*therapeutic use
Sodium Bicarbonate/*therapeutic use
Adult ; Anti-Ulcer Agents/therapeutic use ; Drug Combinations ; Female ; Gastric Acid/metabolism ; Humans ; Hydrogen-Ion Concentration ; Malaysia ; Male ; Middle Aged ; Obesity ; Postprandial Period/drug effects ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Editorial: moving towards appropriate use of proton pump inhibitors. Authors' reply.
Autorzy :
Schnoll-Sussman F; Division of Gastroenterology and Hepatology, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, NY, USA.
Katz PO; Division of Gastroenterology and Hepatology, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, NY, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Jan; Vol. 51 (1), pp. 177.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Eosinophilic Esophagitis*
Gastroesophageal Reflux*
Physicians*
Humans ; Proton Pump Inhibitors
Opinia redakcyjna
Tytuł :
Editorial: the problem of supragastric belching needs to be heard.
Autorzy :
Halland M; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Katzka DA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Oct; Vol. 50 (7), pp. 832-833.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Eructation*
Gastroesophageal Reflux*
Cognitive Behavioral Therapy ; Follow-Up Studies ; Humans ; Manometry
Opinia redakcyjna
Tytuł :
Editorial: the overlap between dyspepsia and gastro-oesophageal reflux-is duodenal eosinophilia the missing link?
Autorzy :
Kanno T; Division of Gastroenterology & Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, Canada.
Moayyedi P; Division of Gastroenterology & Farncombe Family Digestive Health Research Institute, Department of Medicine, McMaster University, Hamilton, Canada.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Aug; Vol. 50 (4), pp. 454-455.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Dyspepsia*
Eosinophilia*
Gastritis*
Gastroesophageal Reflux*
Duodenum ; Humans
Opinia redakcyjna
Tytuł :
Editorial: the overlap between dyspepsia and gastro-oesophageal reflux-is duodenal eosinophilia the missing link? Authors' reply.
Autorzy :
Ronkainen J; Center for Life Course Health Research, University of Oulu, Oulu, Finland.; Primary Health Care Center, Tornio, Finland.; Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.
Aro P; Arokero OY, Tornio, Finland.
Walker MM; Faculty of Health and Medicine, Priority Research Center for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia.; Australian GI Research Alliance (AGIRA), Canberra, Australia.
Agréus L; Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.; Faculty of Health and Medicine, Priority Research Center for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia.; Australian GI Research Alliance (AGIRA), Canberra, Australia.
Johansson SE; Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.
Jones M; Psychology Department, Macquarie University, North Ryde, NSW, Australia.
Talley NJ; Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.; Faculty of Health and Medicine, Priority Research Center for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia.; Australian GI Research Alliance (AGIRA), Canberra, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Aug; Vol. 50 (4), pp. 455-456.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Dyspepsia*
Eosinophilia*
Esophagitis, Peptic*
Gastroesophageal Reflux*
Duodenum ; Humans
Opinia redakcyjna
Tytuł :
Duodenal eosinophilia is associated with functional dyspepsia and new onset gastro-oesophageal reflux disease.
Autorzy :
Ronkainen J; Center for Life Course Health Research, University of Oulu, Oulu, Finland.; Primary Health Care Center, Tornio, Finland.; Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.
Aro P; Arokero OY, Tornio, Finland.
Walker MM; Faculty of Health and Medicine, Priority Research Center for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia.; Australian GI Research Alliance (AGIRA), Canberra, Australia.
Agréus L; Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.; Faculty of Health and Medicine, Priority Research Center for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia.; Australian GI Research Alliance (AGIRA), Canberra, Australia.
Johansson SE; Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.
Jones M; Psychology Department, Macquarie University, North Ryde, NSW, Australia.
Talley NJ; Division of Family Medicine and Primary Care, Karolinska Institutet, Stockholm, Sweden.; Faculty of Health and Medicine, Priority Research Center for Digestive Health and Neurogastroenterology, University of Newcastle, Callaghan, NSW, Australia.; Australian GI Research Alliance (AGIRA), Canberra, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Jul; Vol. 50 (1), pp. 24-32. Date of Electronic Publication: 2019 May 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Duodenum*/immunology
Duodenum*/pathology
Duodenum*/physiopathology
Abdominal Pain/*epidemiology
Dyspepsia/*epidemiology
Eosinophilia/*epidemiology
Gastroesophageal Reflux/*epidemiology
Abdominal Pain/immunology ; Abdominal Pain/pathology ; Abdominal Pain/physiopathology ; Case-Control Studies ; Dyspepsia/immunology ; Dyspepsia/pathology ; Dyspepsia/physiopathology ; Eosinophilia/immunology ; Eosinophilia/pathology ; Eosinophilia/physiopathology ; Female ; Follow-Up Studies ; Gastroesophageal Reflux/immunology ; Gastroesophageal Reflux/pathology ; Gastroesophageal Reflux/physiopathology ; Humans ; Male ; Middle Aged ; Surveys and Questionnaires ; Sweden/epidemiology
Czasopismo naukowe
Tytuł :
Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms.
Autorzy :
Holmberg D; Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Santoni G; Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Xie S; Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Lagergren J; Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Jul; Vol. 50 (2), pp. 159-166. Date of Electronic Publication: 2019 Jun 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gastric Bypass*/adverse effects
Gastric Bypass*/statistics & numerical data
Gastroesophageal Reflux/*complications
Gastroesophageal Reflux/*surgery
Obesity/*complications
Obesity/*surgery
Adult ; Aged ; Cohort Studies ; Comorbidity ; Female ; Follow-Up Studies ; Gastroesophageal Reflux/drug therapy ; Gastroesophageal Reflux/epidemiology ; Histamine H2 Antagonists/therapeutic use ; Humans ; Male ; Middle Aged ; Obesity/drug therapy ; Obesity/epidemiology ; Proton Pump Inhibitors/therapeutic use ; Recurrence ; Sweden/epidemiology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Editorial: gastric bypass for GERD in class II & III obesity-still the best option?
Autorzy :
Triggs JR; Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Kahrilas PJ; Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 Jun; Vol. 49 (12), pp. 1535-1536.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Gastric Bypass*
Gastroesophageal Reflux*
Obesity, Morbid*
Humans ; Obesity
Opinia redakcyjna
Tytuł :
Letter: studies of salivary pepsin in patients with gastro-oesophageal reflux disease.
Autorzy :
Dettmar PW; RD Biomed Limited, Castle Hill Hospital, Cottingham, UK.
Woodcock AD; RD Biomed Limited, Castle Hill Hospital, Cottingham, UK.
Wilcox MD; Institute for Cell and Molecular Biosciences, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
Chater PI; Institute for Cell and Molecular Biosciences, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
Pearson JP; Institute for Cell and Molecular Biosciences, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 May; Vol. 49 (9), pp. 1248-1249.
Typ publikacji :
Letter; Comment
MeSH Terms :
Gastroesophageal Reflux*
Pepsin A*
Humans
Opinia redakcyjna
Tytuł :
Studies of salivary pepsin in patients with gastro-oesophageal reflux disease.
Autorzy :
Race C; Department of Gastroenterology, Northern General Hospital, Sheffield, UK.
Chowdry J; Molecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Russell JM; Department of Corporate Information and Computer Services, University of Sheffield, Sheffield, UK.
Corfe BM; Molecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.; Insigneo Institute, University of Sheffield, Sheffield, UK.
Riley SA; Department of Gastroenterology, Northern General Hospital, Sheffield, UK.; Insigneo Institute, University of Sheffield, Sheffield, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 May; Vol. 49 (9), pp. 1173-1180.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Gastroesophageal Reflux/*diagnosis
Pepsin A/*analysis
Saliva/*chemistry
Adult ; Aged ; Biomarkers/analysis ; Biomarkers/metabolism ; Case-Control Studies ; Diagnosis, Differential ; Enzyme-Linked Immunosorbent Assay ; Feasibility Studies ; Female ; Gastroesophageal Reflux/metabolism ; Humans ; Male ; Middle Aged ; Pepsin A/metabolism ; Pilot Projects ; Predictive Value of Tests ; Saliva/metabolism ; Sensitivity and Specificity ; Surveys and Questionnaires ; Young Adult
Czasopismo naukowe
Tytuł :
Letter: studies of salivary pepsin in patients with gastro-oesophageal reflux disease. Authors' reply.
Autorzy :
Corfe BM; Molecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Chowdry J; Molecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Russell JM; Department of Corporate Information and Computer Services, University of Sheffield, Sheffield, UK.
Race C; Department of Gastroenterology, Northern General Hospital, Sheffield, UK.
Riley SA; Department of Gastroenterology, Northern General Hospital, Sheffield, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 May; Vol. 49 (9), pp. 1249-1250.
Typ publikacji :
Letter; Comment
MeSH Terms :
Gastroesophageal Reflux*
Pepsin A*
Humans
Opinia redakcyjna
Tytuł :
Editorial: breaking the cycle of cough in GERD-neuromodulators to the rescue? Authors' reply.
Autorzy :
Dong R; Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Xu X; Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Yu L; Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Qiu Z; Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 May; Vol. 49 (9), pp. 1243-1244.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Cough*
Gastroesophageal Reflux*
Baclofen ; Gabapentin ; Humans ; Neurotransmitter Agents
Opinia redakcyjna
Tytuł :
Editorial: breaking the cycle of cough in GERD-neuromodulators to the rescue?
Autorzy :
Naik RD; Division of Gastroenterology, Hepatology, and Nutrition, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, Tennessee.
Vaezi MF; Division of Gastroenterology, Hepatology, and Nutrition, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, Tennessee.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 May; Vol. 49 (9), pp. 1242-1243.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Cough*
Gastroesophageal Reflux*
Baclofen ; Gabapentin ; Humans ; Neurotransmitter Agents
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies